Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neu Base Therapeutics Inc (NBSE)

Neu Base Therapeutics Inc (NBSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neu Base Therapeutics Inc 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 USA

www.neubasetherapeutics.com P: 412-763-3350

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

NeuBase Therapeutics Inc. is a biotechnology company. It is engaged in developing antisense therapies to address genetic diseases. The company's proprietary platform includes PATrOL(TM). NeuBase Therapeutics Inc., formerly known as Ohr Pharmaceutical Inc., is based in Pittsburgh, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,418
Enterprise Value, $K -15,972
Shares Outstanding, K 3,752
Float, K 3,455
% Float 92.10%
Short Volume Ratio 0.15
% of Insider Shareholders 7.90%
% of Institutional Shareholders 12.37%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -4,370 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,820 K
EBIT, $ -12,660 K
EBITDA, $ -12,340 K

Growth:

1-Year Return -90.05%
3-Year Return -99.63%
5-Year Return -99.30%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.19%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.95 on 11/09/23
Next Earnings Date 01/01/70
Earnings Per Share ttm -7.21
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 06/15/23

NBSE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 2.45
Interest Coverage -0.34
60-Month Beta 0.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar